Profile data is unavailable for this security.
About the company
Gabather AB is a Sweden-based company engaged pharmaceutical industry. The Company develops drug candidates for the treatment of several diseases originating in the central nervous system (CNS). The Company mainly focuses on anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as conginition-enhancing treatments, including Alzheimer’s disease.
- Revenue in SEK (TTM)0.00
- Net income in SEK-4.65m
- Incorporated2014
- Employees2.00
- LocationGabather ABForskargatan 20 J, Bygg 215 NSODERTALJE 151 36SwedenSWE
- Phone+46 462863600
- Websitehttps://www.gabather.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PCI Biotech Holding ASA | 4.45m | -19.50m | 4.89m | 7.00 | -- | 0.4116 | -- | 1.10 | -0.5502 | -0.5502 | 0.1256 | 0.3353 | 0.1676 | -- | 0.896 | 669,714.30 | -73.44 | -41.44 | -92.22 | -46.61 | -- | -- | -438.10 | -897.91 | -- | -- | 0.022 | -- | 125.25 | -6.43 | 19.19 | -- | -- | -- |
| Stayble Therapeutics AB | 0.00 | -6.93m | 11.56m | 2.00 | -- | 1.67 | -- | -- | -0.1227 | -0.1227 | 0.00 | 0.1076 | 0.00 | -- | -- | -- | -77.50 | -74.45 | -89.43 | -84.74 | -- | -- | -- | -- | -- | -3,463.50 | 0.1094 | -- | -- | -- | 44.21 | -- | -- | -- |
| Respiratorius AB (publ) | 0.00 | -6.95m | 11.66m | -- | -- | 0.3809 | -- | -- | -1.15 | -1.15 | 0.00 | 3.87 | 0.00 | -- | -- | -- | -22.10 | -- | -22.91 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.10 | -- | -- | -- |
| Novakand Pharma AB | 0.00 | -47.23m | 12.36m | 5.00 | -- | 0.8205 | -- | -- | -0.3897 | -0.3897 | 0.00 | 0.1243 | 0.00 | -- | -- | 0.00 | -112.94 | -58.37 | -122.10 | -66.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.98 | -- | -- | -- |
| Gabather AB | 0.00 | -4.65m | 17.70m | 2.00 | -- | -- | -- | -- | -0.0384 | -0.0384 | 0.00 | -0.0111 | 0.00 | -- | -- | 0.00 | -209.07 | -67.13 | -- | -90.59 | -- | -- | -- | -- | -- | -76.57 | -- | -- | -- | -- | 17.84 | -- | -- | -- |
| Fluicell AB | 2.68m | -9.86m | 18.00m | 11.00 | -- | 1.67 | -- | 6.71 | -7.18 | -7.18 | 1.95 | 7.86 | 0.1257 | -2.79 | 3.22 | 268,100.00 | -46.21 | -89.03 | -62.52 | -133.15 | 428.87 | 86.83 | -367.74 | -656.39 | 0.6057 | -- | 0.00 | -- | -44.31 | -5.66 | 41.59 | -- | 33.86 | -- |
| Lumito AB (publ) | 81.51k | -48.06m | 18.44m | 8.00 | -- | 0.1331 | -- | 226.27 | -20.16 | -20.16 | 0.0253 | 40.27 | 0.0008 | -0.4224 | 0.0791 | 6,792.50 | -47.58 | -24.12 | -62.09 | -26.46 | 546.44 | -- | -58,966.97 | -138,894.00 | 0.2668 | -22.92 | 0.1994 | -- | -- | -- | -61.08 | -- | -30.66 | -- |
| Peptonic Medical AB | 15.69m | -48.98m | 22.41m | 3.00 | -- | 0.3207 | -- | 1.43 | -0.0068 | -0.0068 | 0.002 | 0.0037 | 0.1994 | 0.6491 | 3.47 | 2,242,000.00 | -62.23 | -52.80 | -86.90 | -72.84 | 67.85 | 54.48 | -312.10 | -141.78 | 0.2747 | -26.44 | 0.2863 | -- | -27.55 | 43.57 | -40.95 | -- | 11.04 | -- |
| ATTANA AB | 4.10m | -12.78m | 23.23m | 6.00 | -- | 0.6845 | -- | 5.66 | -0.0154 | -0.0154 | 0.0047 | 0.0132 | 0.1425 | -0.7611 | 1.02 | 656,600.00 | -44.37 | -37.91 | -61.34 | -48.09 | 161.16 | 189.23 | -311.34 | -305.50 | 0.6079 | -3.79 | 0.1315 | -- | -18.77 | -8.69 | 7.33 | -- | 8.51 | -- |
| Aptahem AB | 0.00 | -7.43m | 26.15m | -- | -- | 0.2127 | -- | -- | -0.6711 | -0.6711 | 0.00 | 3.77 | 0.00 | -- | -- | -- | -11.21 | -30.70 | -11.57 | -34.24 | -- | -- | -- | -- | -- | -44.15 | 0.00 | -- | -- | -- | 22.90 | -- | 88.99 | -- |
| Guard Therapeutics Intrntnl AB (publ) | 0.00 | -108.85m | 33.68m | 5.00 | -- | 0.8289 | -- | -- | -6.43 | -6.43 | 0.00 | 2.01 | 0.00 | -- | -- | -- | -198.12 | -84.57 | -265.33 | -96.74 | -- | -- | -- | -- | -- | -64.77 | -- | -- | -- | -- | -13.31 | -- | -- | -- |
| Modus Therapeutics Holding AB | 0.00 | -17.94m | 35.27m | 2.00 | -- | 2.42 | -- | -- | -0.1796 | -0.1796 | 0.00 | 0.1196 | 0.00 | -- | -- | 0.00 | -137.62 | -123.65 | -167.64 | -208.97 | -- | -- | -- | -- | -- | -63.99 | 0.00 | -- | -- | -- | 13.14 | -- | -- | -- |
Data as of Feb 27 2026. Currency figures normalised to Gabather AB's reporting currency: Swedish Krona SEK
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FCG Fonder ABas of 31 Mar 2025 | 7.93k | 0.00% |
Data from 30 Dec 2025 - 30 Dec 2025Source: FactSet Research Systems Inc.
